Pharma-Bio Serv Announces Results for the Quarter Ended January 31, 2022
DORADO, PUERTO RICO / ACCESSWIRE / March 17, 2022 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a...
Day: March 17, 2022
Viveve Reports Full Year 2021 Financial Results and Provides Corporate Update
Reported total revenue for year end 2021 of $6.4 million representing 17% year-over-year growthEnrollment completed in U.S. pivotal PURSUIT trial...
AllStar Signs LOI to Acquire 25% of Metaverse Technology Company Advent Galaxy Inc.
MIAMI, FL / ACCESSWIRE / March 17, 2022 / AllStar Health Brands (OTC PINK:ALST) ("Allstar" or the "Company"), an emerging...
Assistance for Long COVID Sufferers Targeted by Health Advance, Inc
Proprietary Techniques for a Burgeoning ProblemNEW YORK, NY / ACCESSWIRE / March 17, 2022 / Health Advance, Inc (OTC PINK:HADV)...
Thomas E. Mannle, Jr. to Join the Advisory Board of Xcelerate, Inc.
MAULDIN, SC / ACCESSWIRE / March 17, 2022 / Xcelerate, Inc. (OTCMarkets:"XCRT) today announced that Thomas E. Mannle, Jr. has...
Smarty Pantz Marketing Launches (AI) Digital Advertising Program to Florida’s Businesses
Fort Lauderdale, Florida--(Newsfile Corp. - March 17, 2022) - With the launch of new (AI) digital advertising programs, Smarty Pantz...
Ondek Works to Solve Some of the Biggest Challenges in America’s Healthcare Industry
HARKER HEIGHTS, TX / ACCESSWIRE / March 17, 2022 / Ondek Enterprise, the $16M company that is changing how short-term...
Health Canada Authorizes Moderna’s COVID-19 Vaccine in Children (6-11 Years)
Announcement follows recent authorization of the Company's mRNA COVID-19 vaccine in Australia and the European Union for active immunization to...
IIOT-OXYS, Inc. and Aingura IIoT Executives Discuss High-Value Partnership
CAMBRIDGE, MA / ACCESSWIRE / March 17, 2022 / Cliff Emmons, CEO of IIOT-OXYS, Inc. (OTC PINK:ITOX), announces the availability...
IONIQ Sciences Announces the Addition of Edison Group as Investor Relations Advisor
SALT LAKE CITY, UT / ACCESSWIRE / March 17, 2022 / IONIQ Sciences, Inc. ("IONIQ" or the "Company") announced today...
Planet 13 Initiates Florida Dispensary Roadmap – Lease Signed for First Florida Dispensary in Jacksonville
LAS VEGAS, NV / ACCESSWIRE / March 17, 2022 / Planet 13 Holdings Inc. (CSE:PLTH)(OTCQX:PLNHF) ("Planet 13" or the "Company"),a...
Smart for Life Products Selected by Amazon for Launch in Singapore
Certain Vitamins and Supplements Will Be the First of the Company’s Products to Launch on Amazon in Southeast AsiaMIAMI, March...
Organogenesis Named One of 50 Highest Growth Companies in Massachusetts by the Boston Business Journal
CANTON, Mass., March 17, 2022 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on...
CPS’ Brian Beckett and Chris Beebe Appointed to The Joint Commission Advisory Council
The Joint Commission Names Two CPS Leaders to Advisory CouncilDUBLIN, Ohio, March 17, 2022 (GLOBE NEWSWIRE) -- CPS Solutions, LLC...
Advaxis Reports First Quarter Ended January 31, 2022 Financial Results and Provides a Business Update
Presented Updated Clinical Data from Ongoing Phase 1/2 Trial of ADXS-503 in NSCLC and Upcoming Milestones Priced Offering of $5...
Grow Therapy Partners With Aetna To Take Its Mental Health Care Services Nationwide
National agreement allows Grow Therapy to offer its provider network to Aetna’s 87 million health plan customersNEW YORK, March 17,...
Amolyt Pharma Announces US IND Clearance for the Ongoing Clinical Trial of AZP-3601 in Patients with Hypoparathyroidism
Top-line safety and efficacy data from ongoing clinical trial in patients with hypoparathyroidism expected mid-2022LYON, France and Cambridge, Mass., March...
CorMedix Inc. Announces the Appointment of Chief Executive Officer
Joseph Todisco to join CorMedix as Chief Executive Officer; Brings significant experience in commercial strategy, business operations and leadership, and...
Supernus Notifies Nasdaq Regarding Non-Compliance with Listing Requirement and Expectation to Regain Compliance
ROCKVILLE, Md., March 17, 2022 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and...
Journey Medical Corporation Announces First Patient Dosed in Phase 3 Clinical Trial Evaluating DFD-29 (Minocycline Modified Release Capsules 40 mg) for the Treatment of Rosacea
Published Phase 2 clinical data show DFD-29 had approximately double the efficacy compared to Doxycycline capsules 40 mg on reducing...